Discover 3,564 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,564
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Los Angeles CA, Portland OR, Missoula MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Fullerton CA, Los Angeles CA, Portland OR,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase2, Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Santa Ana CA, Henderson NV, El Paso TX, Austin TX,
Sponsor: Centessa Pharmaceuticals (UK) Limited
Sex: All
Age: 18 - 65
Code: NCT07096674
Phase2, Recruiting
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
for
CTCL
Location: Duarte CA, Rochester NY, Richmond VA, New Haven CT,
Sponsor: Prescient Therapeutics, Ltd.
Sex: All
Age: 18+
Code: NCT06854653
Phase2, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer
Location: Newport Beach CA, Los Angeles CA, Chandler AZ, Reno NV,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial